Recent Updates
Recently added Catalysts
CELC Positive Sentiment

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

Tuesday, April 1, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celcuity Inc. has announced that its CEO, Brian Sullivan, will be presenting at two upcoming virtual investor conferences: the Stifel 2025 Virtual Targeted Oncology Forum and the 24th Annual Needham Virtual Healthcare Conference. These events are scheduled for April 9 and April 10, 2025, respectively, and will feature opportunities for one-on-one meetings with investors. Live webcasts of the presentations will be available, underscoring the company's ongoing commitment to investor relations and transparency in its oncology-focused initiatives.
Price reaction · baseline $10.11 (2025-03-31 close) · hit after-hours · clean, no other CELC news in the window
day 0 close
-8.1%
day 1
-7.4%
day 3 · peak
-14.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Celcuity is actively engaging with investors through presentations.
  • The company is showcasing its commitment to targeted therapies in oncology.
  • CEO Brian Sullivan's involvement highlights leadership engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
14.9%
average across 6 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
Gedatolisib
Phase 3 · Breast Cancer

Full Press Release Details

MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:
A fireside chat at the Stifel 2025 Virtual Targeted Oncology Forum at 10:00 a.m. ET on Wednesday, April 9, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/stifel99/celc/2065375; and
A fireside chat at the 24th Annual Needham Virtual Healthcare Conference at 11:00 a.m. ET on Thursday, April 10, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/needham146/celc/2212811.
Alternatively, the live webcasts will be accessible from the Investors section of the company's website at https://ir.celcuity.com/events-presentations/ with a replay available shortly after the live events.
View source version of release on GlobeNewswire.com

Frequently Asked Questions

When is the investor conference with Brian Sullivan?

Brian Sullivan will present on April 9, 2025, at the Stifel Virtual Forum.

Where can I watch the live webcasts of the events?

Live webcasts will be available on Celcuity's investor relations website.

What time is the Needham Virtual Healthcare Conference?

The Needham Virtual Healthcare Conference is at 11:00 a.m. ET on April 10, 2025.

Who is presenting at the investor conferences?

Brian Sullivan, CEO and Co-founder of Celcuity, will be presenting.

How can I access the replay of the webcasts?

Replays of the webcasts will be available shortly after the live events.

ShareAdd on Google
Tags: CELC Viatris Investor Conferences Healthcare Celcuity targeted therapies oncology investor conference Brian Sullivan
Last updated: Apr 1, 2025

Biotech snapshot

Cash runway
$754M liquidity · $18M/mo burn
~41 mo
Minimal dilution risk
Lead asset
GedatolisibPhase 3
Breast Cancer →

Catalyst track record

+27%
best trade around CELC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CELC.

See every catalyst's timing & PoA →